NCT01389232View on ClinicalTrials.gov

The SeriScaffold® Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery in Europe

NACompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

February 28, 2015

Conditions
Soft Tissue Support and Repair
Interventions
DEVICE

SeriScaffold® Surgical Scaffold

A CE Marked, 510(k) cleared, knitted, multi-filament, bioengineered, silk mesh indicated for use as a transitory scaffold for soft tissue support and repair

Trial Locations (5)

Unknown

Düsseldorf

Munich

Milan

Barcelona

Nottingham

All Listed Sponsors
lead

Sofregen Medical, Inc.

INDUSTRY

NCT01389232 - The SeriScaffold® Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery in Europe | Biotech Hunter | Biotech Hunter